Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

341 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor.
Winograd-Katz SE, Levitzki A. Winograd-Katz SE, et al. Among authors: levitzki a. Oncogene. 2006 Nov 30;25(56):7381-90. doi: 10.1038/sj.onc.1209737. Epub 2006 Jun 19. Oncogene. 2006. PMID: 16785992
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).
Peng Z, Maxwell DS, Sun D, Bhanu Prasad BA, Schuber PT Jr, Pal A, Ying Y, Han D, Gao L, Wang S, Levitzki A, Kapuria V, Talpaz M, Young M, Showalter HD, Donato NJ, Bornmann WG. Peng Z, et al. Among authors: levitzki a. Bioorg Med Chem. 2014 Feb 15;22(4):1450-8. doi: 10.1016/j.bmc.2013.12.048. Epub 2014 Jan 3. Bioorg Med Chem. 2014. PMID: 24457091 Free PMC article.
Convergence of logic of cellular regulation in different premalignant cells by an information theoretic approach.
Kravchenko-Balasha N, Remacle F, Gross A, Rotter V, Levitzki A, Levine RD. Kravchenko-Balasha N, et al. Among authors: levitzki a. BMC Syst Biol. 2011 Mar 16;5:42. doi: 10.1186/1752-0509-5-42. BMC Syst Biol. 2011. PMID: 21410932 Free PMC article.
HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment.
Zigler M, Shir A, Joubran S, Sagalov A, Klein S, Edinger N, Lau J, Yu SF, Mizraji G, Globerson Levin A, Sliwkowski MX, Levitzki A. Zigler M, et al. Among authors: levitzki a. Cancer Immunol Res. 2016 Aug;4(8):688-97. doi: 10.1158/2326-6066.CIR-15-0203. Epub 2016 May 30. Cancer Immunol Res. 2016. PMID: 27241844 Free article.
Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC).
Levitzki A. Levitzki A. Front Oncol. 2012 Feb 8;2:4. doi: 10.3389/fonc.2012.00004. eCollection 2012. Front Oncol. 2012. PMID: 22649773 Free PMC article.
Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance.
Levitzki A. Levitzki A. Annu Rev Pharmacol Toxicol. 2013;53:161-85. doi: 10.1146/annurev-pharmtox-011112-140341. Epub 2012 Oct 8. Annu Rev Pharmacol Toxicol. 2013. PMID: 23043437 Review.
Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks.
Su SP, Flashner-Abramson E, Klein S, Gal M, Lee RS, Wu J, Levitzki A, Daly RJ. Su SP, et al. Among authors: levitzki a. Mol Cancer Ther. 2018 May;17(5):931-942. doi: 10.1158/1535-7163.MCT-17-0377. Epub 2018 Feb 12. Mol Cancer Ther. 2018. PMID: 29440449 Free article.
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer.
Ibuki N, Ghaffari M, Reuveni H, Pandey M, Fazli L, Azuma H, Gleave ME, Levitzki A, Cox ME. Ibuki N, et al. Among authors: levitzki a. Mol Cancer Ther. 2014 Dec;13(12):2827-39. doi: 10.1158/1535-7163.MCT-13-0842. Epub 2014 Sep 29. Mol Cancer Ther. 2014. PMID: 25267499 Free article.
Amino acid starvation sensitizes cancer cells to proteasome inhibition.
Mizrachy-Schwartz S, Cohen N, Klein S, Kravchenko-Balasha N, Levitzki A. Mizrachy-Schwartz S, et al. Among authors: levitzki a. IUBMB Life. 2010 Oct;62(10):757-63. doi: 10.1002/iub.377. IUBMB Life. 2010. PMID: 20931634
Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytes.
Kravchenko-Balasha N, Mizrachy-Schwartz S, Klein S, Levitzki A. Kravchenko-Balasha N, et al. Among authors: levitzki a. J Biol Chem. 2009 Apr 24;284(17):11717-27. doi: 10.1074/jbc.M900217200. Epub 2009 Feb 16. J Biol Chem. 2009. PMID: 19221178 Free PMC article.
341 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page